- Home
- PT vs IBIO Comparison
PT vs IBIO Comparison
Compare PT & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PT
- IBIO
- Stock Information
- Founded
- PT 2012
- IBIO 2008
- Country
- PT China
- IBIO United States
- Employees
- PT N/A
- IBIO N/A
- Industry
- PT Computer Software: Programming Data Processing
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PT Technology
- IBIO Health Care
- Exchange
- PT Nasdaq
- IBIO Nasdaq
- Market Cap
- PT 14.7M
- IBIO 16.4M
- IPO Year
- PT 2018
- IBIO N/A
- Fundamental
- Price
- PT $0.99
- IBIO $1.25
- Analyst Decision
- PT
- IBIO Strong Buy
- Analyst Count
- PT 0
- IBIO 4
- Target Price
- PT N/A
- IBIO $4.50
- AVG Volume (30 Days)
- PT 92.8K
- IBIO 8.4M
- Earning Date
- PT 09-19-2025
- IBIO 10-31-2025
- Dividend Yield
- PT N/A
- IBIO N/A
- EPS Growth
- PT N/A
- IBIO N/A
- EPS
- PT N/A
- IBIO N/A
- Revenue
- PT $4,961,892.00
- IBIO $400,000.00
- Revenue This Year
- PT N/A
- IBIO N/A
- Revenue Next Year
- PT N/A
- IBIO $33.34
- P/E Ratio
- PT N/A
- IBIO N/A
- Revenue Growth
- PT 9.20
- IBIO 77.78
- 52 Week Low
- PT $0.76
- IBIO $0.56
- 52 Week High
- PT $1.38
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- PT 53.71
- IBIO 51.58
- Support Level
- PT $0.96
- IBIO $1.02
- Resistance Level
- PT $1.06
- IBIO $1.81
- Average True Range (ATR)
- PT 0.06
- IBIO 0.27
- MACD
- PT 0.01
- IBIO -0.01
- Stochastic Oscillator
- PT 63.25
- IBIO 29.11
About PT Pintec Technology Holdings Limited
Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.